The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative (Q42651930)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative |
scientific article |
Statements
1 reference
The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative (English)
1 reference
Timpone JG
1 reference
Wright DJ
1 reference
Li N
1 reference
Egorin MJ
1 reference
Enama ME
1 reference
Mayers J
1 reference
Galetto G
1 reference
1 March 1997
1 reference
1 reference
13
1 reference
4
1 reference
305-315
1 reference
Identifiers
1 reference
1 reference